Further notifications - Archive

Here you find further notifications about Fraunhofer ITMP based on links to external websites.

News / Press Release / 2.12.2021

Funding for the LOEWE centers DRUID and TBG extended

 

Fraunhofer ITMP is a partner of the LOEWE centers DRUID (Novel Drug Targets against Poverty-Related and Neglected Tropical Infectious Diseases) and TBG (Translational Biodiversity Genomics). Following the successful completion of the start-up phase, both LOEWE centers will now continue to receive funding from the state of Hesse in their operational phase and will receive project and construction funding totaling approximately 34.4 million euros for the duration of three years.

News / Press Release / 23.11.2021

The EU invests in a promising new COVID-19 therapy

 

The COVend research project aims to deliver a new therapy against COVID-19 that prevents the severe stages of the disease. Fraunhofer ITMP is one of the partners of the multidisciplinary consortium, which unites 17 partners from 13 European countries with expertise from different disciplines, including (cell) biology, ICT expertise for AI based evaluations, pharma, economics, and social sciences, as well as clinical expertise. 

News / Press Release / 2.11.2021

Fraunhofer Institutes present the first prototype for digital twins of patients

 

Optimum prevention, diagnosis and treatment in just one click: As part of the “MED²ICIN” lighthouse project, seven Fraunhofer Institutes, among them Fraunhofer ITMP, are presenting the first prototype of a digital patient model. This prototype revolutionizes the very foundation of personalized and cost-optimized treatment, opening up new perspectives. It has already been tested at University Hospital Frankfurt.

News / 29.10.2021

Honorary Doctorate for Prof. Jennifer Dressman

 

 

The University of Southern Denmark (SDU) awards honorary doctorates to researchers whom the University wishes to honour for their scientific work. As part of the annual University Celebration on October 29, 2021, Fraunhofer ITMP employee Prof. Jennifer Dressman received an honorary doctorate from SDU's Faculty of Science for her work on the pharmaceutical ecosystem.

News / 12.8.2021

Fraunhofer ITMP employee worldwide "psoriatic arthritis expert"

 

PD Dr. Frank Behrens, Deputy Director of Fraunhofer ITMP and Head of the Clinical Research division, is listed as an expert in psoriatic arthritis on the Expertscape expert platform. This places him in the top 1% of scientists worldwide who have written on the topic of psoriatic arthritis in the last 10 years. 

Expertscape uses PubMed-based algorithms to objectively rank individuals and institutions according to their expertise in more than 29,000 biomedical topics.

News / 12.5.2021

Drug Repurposing as strategy in the fight against COVID-19

 

After the recent successes in vaccine development, drug development against the COVID-19 disease is moving into focus. Fraunhofer ITMP is applying Drug Repurposing strategies in various projects focusing on SARS-CoV-2. Repurposing strategies use substances that have undergone clinical testing in other disease indications and investigate their effect against COVID-19. These strategies can not only identify effective substances for different stages of the disease, but also contribute to a better understanding of the mechanisms of action of this disease. 

News / 26.4.2021

iCAIR® delivers first results in the fight against Sars-CoV-2

 

Fraunhofer ITMP is a temporary project partner for the additional research project focussing on the development of inhalable drugs to combat SARS-CoV-2, started in May 2020 within the frame of the international iCAIR® consortium. The iCAIR® research team, coordinated by Fraunhofer ITEM, can already report promising results for this project.